GRANULESPharmaceuticals
Granules India Ltd — PE Ratio & Valuation Analysis
₹620.40
-0.75%
Current P/E27.00xPrice to earnings
Industry P/E31.77xSector average
4Y Avg P/E22.3x21.1% above avg
✅
15.0% Discount to Industry
GRANULES P/E 27.00x vs sector avg 31.77x
📊
Historical PE Ratio
| Year | EPS (₹) | Year-end Price | PE Ratio |
|---|---|---|---|
| 2024 | ₹16.72 | ₹592 | 35.4x |
| 2023 | ₹21.00 | ₹405 | 19.3x |
| 2022 | ₹16.60 | ₹319 | 19.2x |
| 2021 | ₹21.95 | ₹336 | 15.3x |
PE = Year-end closing price ÷ Diluted EPS. Source: NSE/BSE filings.
💡
Understanding Granules India Ltd Valuation
Granules India Ltd (GRANULES) currently trades at 27.00x earnings. The Pharmaceuticals sector average PE is 31.77x. GRANULES is trading at a discount to peers — may indicate relative value. Historically, GRANULES has traded at an average PE of 22.3x — it is currently above that level. Always evaluate PE alongside earnings growth (PEG ratio), return on equity, debt levels and business quality. A lower PE isn't always better. Educational data only — not investment advice.
ROE
13.86%
Dividend Yield
0.26%
More on Granules India Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.